(0.14%) 5 315.51 points
(0.20%) 39 987 points
(0.09%) 16 757 points
(0.78%) $79.24
(3.02%) $2.49
(-0.39%) $2 385.50
(0.54%) $29.89
(-0.34%) $1 066.50
(0.12%) $0.920
(0.27%) $10.69
(0.06%) $0.789
(0.25%) $90.91
@ $22.52
Issued: 14 Feb 2024 @ 15:56
Return: 66.74%
Previous signal: Feb 14 - 09:38
Previous signal:
Return: -2.04 %
Live Chart Being Loaded With Signals
Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection...
Stats | |
---|---|
Today's Volume | 101 188 |
Average Volume | 485 967 |
Market Cap | 1.51B |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.760 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.114 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-25 | Fairmount Funds Management Llc | Buy | 3 639 680 | Common Stock |
2024-04-25 | Fairmount Funds Management Llc | Sell | 90 992 | Series A Preferred Stock |
2024-02-15 | Turtle Cameron | Buy | 400 | Common Stock |
2024-02-01 | Mckenna Mark C. | Buy | 40 000 | Stock Option (Right to Buy) |
2024-02-01 | Mckenna Mark C. | Sell | 477 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
12.85 |
Last 11 transactions |
Buy: 4 513 535 | Sell: 4 003 472 |
Volume Correlation
Spyre Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Spyre Therapeutics, Inc. Correlation - Currency/Commodity
Spyre Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $886 000 |
Gross Profit: | $-78 000.00 (-8.80 %) |
EPS: | $-49.12 |
FY | 2023 |
Revenue: | $886 000 |
Gross Profit: | $-78 000.00 (-8.80 %) |
EPS: | $-49.12 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators